Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations.

Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) had completed an inspection at its wholly owned subsidiary, Auroactive Pharma, located in Andhra Pradesh.

Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) conducted an inspection at Auroactive Pharma (a wholly owned subsidiary of the Company), which manufactures ...

Pune, July 05, 2024 (GLOBE NEWSWIRE) -- Active Pharmaceutical Ingredient Market Analysis: “According to SNS Insider Research, The Active Pharmaceutical Ingredient Market is valued at USD 239.45 ...

Industry leaders say the inclusion of 77 raw materials under new or expanded duty concessions will help reduce procurement ...

India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player. The Ahmedabad-based drugmaker today reported ...

Japanese pharmaceutical contract development and manufacturing organization (CDMO) Peptistar has integrated Asahi Kasei's ...

Hyderabad-based HRV Pharma is attempting to redefine the traditional pharmaceutical business model by building an active pharmaceutical ingredient (API) company without owning any manufacturing ...

QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...

Dublin, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients Directory 2025" has been added to ResearchAndMarkets.com's offering. Published annually the Active Pharmaceutical ...

NewsVoir Mumbai (Maharashtra) [India], October 12: Flawless Pharma Pvt. Ltd. has engaged with a major European contract development and manufacturing organization (CDMO) & a leading African firm in ...

Luxembourg-based C2 Pharma, which already has a manufacturing agreement with Laurus Labs in India, has now bought a new supply of digoxin API. (Lauras Labs) () C2 Pharma, which concentrates on hard-to ...